Lobbying Filing Details

Total Spending

$60,000

Activities

2

Lobbyists

1

Gov't Entities

8

Filing Information
Filing UUID:
ddbc4042-83ec-4f4c-b998-08e869aa500d
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 05, 2026 at 10:18 AM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
LMH STRATEGIC SOLUTIONS
Washington, District of Columbia
Client
REGENXBIO INC.

Biotechnology company.

Maryland, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.

Lobbyists (1)
  • ALANNA TEMME
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • Health & Human Services, Dept of (HHS)
Activity 2
Pharmacy

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.

Lobbyists (1)
  • ALANNA TEMME
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved October 30, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.